Literature DB >> 27681693

Pathologic High-risk Lesions, Diagnosis and Management.

Melissa Murray1.   

Abstract

Percutaneous imaging-guided core needle biopsy (CNB) is a less invasive and less expensive alternative to surgical biopsy for the evaluation of breast lesions. After a CNB the radiologist determine if there is concordance between the pathology, imaging, and clinical findings. Patient management after CNB diagnosis of high-risk breast lesion varies. Surgical excision is warranted for lesions yielding a CNB diagnosis of ADH; however controversy exists regarding the need for surgical excision after CNB diagnosis of radial scar, papillary lesion, atypical lobular hyperplasia (ALH), or lobular carcinoma in situ (LCIS). Repeat CNB or surgical excision is warranted if histologic findings and imaging findings are discordant.

Entities:  

Mesh:

Year:  2016        PMID: 27681693      PMCID: PMC5079293          DOI: 10.1097/GRF.0000000000000234

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  24 in total

1.  Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.

Authors:  S J Schnitt; J L Connolly; F A Tavassoli; R E Fechner; R L Kempson; R Gelman; D L Page
Journal:  Am J Surg Pathol       Date:  1992-12       Impact factor: 6.394

2.  Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary?

Authors:  Niamh Conlon; Clare D'Arcy; Jennifer B Kaplan; Zenica L Bowser; Anibal Cordero; Edi Brogi; Adriana D Corben
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

3.  Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.

Authors:  Monica Rizzo; Jared Linebarger; Michael C Lowe; Lin Pan; Sheryl G A Gabram; Leonel Vasquez; Michael A Cohen; Marina Mosunjac
Journal:  J Am Coll Surg       Date:  2012-01-11       Impact factor: 6.113

4.  Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation.

Authors:  D Georgian-Smith; T J Lawton
Journal:  AJR Am J Roentgenol       Date:  2001-05       Impact factor: 3.959

Review 5.  Anatomic markers of human premalignancy and risk of breast cancer.

Authors:  D L Page; W D Dupont
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

6.  Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?

Authors:  Lavinia P Middleton; Shakeitha Grant; Tanya Stephens; Carol B Stelling; Nour Sneige; Aysegul A Sahin
Journal:  Mod Pathol       Date:  2003-02       Impact factor: 7.842

7.  Radial scars diagnosed on breast core biopsy: Frequency of atypia and carcinoma on excision and implications for management.

Authors:  Alana R Donaldson; Leah Sieck; Christine N Booth; Benjamin C Calhoun
Journal:  Breast       Date:  2016-06-29       Impact factor: 4.380

8.  Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.

Authors:  Fresia Pareja; Adriana D Corben; Sandra B Brennan; Melissa P Murray; Zenica L Bowser; Kiran Jakate; Christopher Sebastiano; Monica Morrow; Elizabeth A Morris; Edi Brogi
Journal:  Cancer       Date:  2016-06-17       Impact factor: 6.860

9.  Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.

Authors:  F Pareja; D A Ferraro; C Rubin; H Cohen-Dvashi; F Zhang; S Aulmann; N Ben-Chetrit; G Pines; R Navon; N Crosetto; W Köstler; S Carvalho; S Lavi; F Schmitt; I Dikic; Z Yakhini; P Sinn; G B Mills; Y Yarden
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

10.  Non-mass-associated intraductal papillomas: is excision necessary?

Authors:  Paul S Weisman; Brian J Sutton; Kalliopi P Siziopikou; Nora Hansen; Seema A Khan; Erin I Neuschler; Stephen M Rohan; Julie M Franz; Megan E Sullivan
Journal:  Hum Pathol       Date:  2013-11-06       Impact factor: 3.466

View more
  2 in total

1.  Performance of a clinical and imaging-based multivariate model as decision support tool to help save unnecessary surgeries for high-risk breast lesions.

Authors:  Dogan S Polat; Jennifer G Schopp; Firouzeh Arjmandi; Jessica Porembka; Venetia Sarode; Deborah Farr; Yin Xi; Basak E Dogan
Journal:  Breast Cancer Res Treat       Date:  2020-10-03       Impact factor: 4.872

2.  Molecular fingerprint of precancerous lesions in breast atypical hyperplasia.

Authors:  Chao Zheng; Hong Ying Jia; Li Yuan Liu; Qi Wang; Hong Chuan Jiang; Li Song Teng; Cui Zhi Geng; Feng Jin; Li Li Tang; Jian Guo Zhang; Xiang Wang; Shu Wang; Fernandez-Escobar Alejandro; Fei Wang; Li Xiang Yu; Fei Zhou; Yu Juan Xiang; Shu Ya Huang; Qin Ye Fu; Qiang Zhang; De Zong Gao; Zhong Bing Ma; Liang Li; Zhi Min Fan; Zhi Gang Yu
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.